Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

374 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Completed

Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).

NCT03208933

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Regional State Budgetary Institution of Healthcare "Regional Cinilcal Hospital"; Pulmonology Barnaul, Altayskiy Kray, Russia
  • GBUZ Regional clinical hospital #4 Chelyabinsk, Evenkija, Russia
  • Central NII tuberkuleza RAMN Moscow, Moscow Oblast, Russia
  • Pulmonologii NII FMBA of Russia Moscow, Moscow Oblast, Russia
View Trial Details
Completed

Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension

NCT02951429

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • ULB Hôpital Erasme Brussels, Belgium
  • Cliniques Universitaires St-Luc Brussels, Belgium
  • UZ Antwerpen Edegem, Belgium
  • UZ Leuven Gasthuisberg Leuven, Belgium
View all 56 locations
View Trial Details
Completed

OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study

NCT03386994

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital Infanta Cristina Badajoz, Spain
  • Hospital Universitario Cruces Barakaldo (Vizcaya), Spain
  • H. del Mar Barcelona, Spain
View all 31 locations
View Trial Details
Completed

Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT02738801

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Municipal Clinical Hospital # 6 Dnipropetrovsk, Ukraine
  • Kharkov City Clinical Hospital # 13 Kharkiv, Ukraine
  • F.G. Yanovskyy Institute of Phthisiatry and Pulmonology 1 Kiev, Ukraine
  • F.G. Yanovskyy Institute of Phthisiatry and Pulmonology 2 Kiev, Ukraine
View Trial Details
Completed

Quality of Life Study in Participants With IPF Under Pirfenidone Treatment

NCT03115619

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Sotiria Hospital for Diseases of the Chest, Academic Department of Pneumonology Athens, Greece
  • University General Hospital of Athens "Attikon", B' University Pulmonary Clinic Chaïdári, Greece
  • University General Hospital of Heraklio, Pulmonary Clinic Heraklio, Greece
  • University General Hospital of Ioannina Ioannina, Greece
View Trial Details
Completed

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

NCT01766817

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham - Division of Pulmonary, Allergy & Criticial Care Birmingham, Alabama, United States
  • St. Joseph's Hospital and Medical Center - Heart Lung Institute/ Clinical Research Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
View all 72 locations
View Trial Details

Related conditions